BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 32730808)

  • 81. How does T cell receptor clustering impact on signal transduction?
    Goyette J; Nieves DJ; Ma Y; Gaus K
    J Cell Sci; 2019 Feb; 132(4):. PubMed ID: 30745330
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Age-related impairment of p56lck and ZAP-70 activities in human T lymphocytes activated through the TcR/CD3 complex.
    Fülöp T; Gagné D; Goulet AC; Desgeorges S; Lacombe G; Arcand M; Dupuis G
    Exp Gerontol; 1999 Apr; 34(2):197-216. PubMed ID: 10363787
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Selected signalling proteins recruited to the T-cell receptor-CD3 complex.
    Ngoenkam J; Schamel WW; Pongcharoen S
    Immunology; 2018 Jan; 153(1):42-50. PubMed ID: 28771705
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Removal of C-terminal SRC kinase from the immune synapse by a new binding protein.
    Rahmouni S; Vang T; Alonso A; Williams S; van Stipdonk M; Soncini C; Moutschen M; Schoenberger SP; Mustelin T
    Mol Cell Biol; 2005 Mar; 25(6):2227-41. PubMed ID: 15743820
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Inhibition of phosphatidylserine synthesis during Jurkat T cell activation. The phosphatase inhibitor, sodium ortho-vanadate bypasses the CD3/T cell receptor-induced second messenger signaling pathway.
    Pelassy C; Breittmayer JP; Aussel C
    Eur J Biochem; 2000 Feb; 267(4):984-92. PubMed ID: 10672006
    [TBL] [Abstract][Full Text] [Related]  

  • 86. In vitro membrane reconstitution of the T-cell receptor proximal signaling network.
    Hui E; Vale RD
    Nat Struct Mol Biol; 2014 Feb; 21(2):133-42. PubMed ID: 24463463
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Involvement of Src-homology-2-domain-containing protein-tyrosine phosphatase 2 in T cell activation.
    Tailor P; Jascur T; Williams S; von Willebrand M; Couture C; Mustelin T
    Eur J Biochem; 1996 May; 237(3):736-42. PubMed ID: 8647120
    [TBL] [Abstract][Full Text] [Related]  

  • 88. The CD3epsilon proline-rich sequence, and its interaction with Nck, is not required for T cell development and function.
    Szymczak AL; Workman CJ; Gil D; Dilioglou S; Vignali KM; Palmer E; Vignali DA
    J Immunol; 2005 Jul; 175(1):270-5. PubMed ID: 15972658
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction.
    Dornan S; Sebestyen Z; Gamble J; Nagy P; Bodnar A; Alldridge L; Doe S; Holmes N; Goff LK; Beverley P; Szollosi J; Alexander DR
    J Biol Chem; 2002 Jan; 277(3):1912-8. PubMed ID: 11694532
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Basal and antigen-induced exposure of the proline-rich sequence in CD3ε.
    de la Cruz J; Kruger T; Parks CA; Silge RL; van Oers NS; Luescher IF; Schrum AG; Gil D
    J Immunol; 2011 Feb; 186(4):2282-90. PubMed ID: 21228347
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The structural basis for membrane assembly of immunoreceptor signalling complexes.
    Dube N; Marzinek JK; Glen RC; Bond PJ
    J Mol Model; 2019 Aug; 25(9):277. PubMed ID: 31456056
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Requirement of CD3 complex-associated signaling functions for expression of rearranged T cell receptor beta VDJ genes in early thymic development.
    Würch A; Biro J; Potocnik AJ; Falk I; Mossmann H; Eichmann K
    J Exp Med; 1998 Nov; 188(9):1669-78. PubMed ID: 9802979
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Precision Engineering of an Anti-HLA-A2 Chimeric Antigen Receptor in Regulatory T Cells for Transplant Immune Tolerance.
    Muller YD; Ferreira LMR; Ronin E; Ho P; Nguyen V; Faleo G; Zhou Y; Lee K; Leung KK; Skartsis N; Kaul AM; Mulder A; Claas FHJ; Wells JA; Bluestone JA; Tang Q
    Front Immunol; 2021; 12():686439. PubMed ID: 34616392
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The lck SH3 domain is required for activation of the mitogen-activated protein kinase pathway but not the initiation of T-cell antigen receptor signaling.
    Denny MF; Kaufman HC; Chan AC; Straus DB
    J Biol Chem; 1999 Feb; 274(8):5146-52. PubMed ID: 9988764
    [TBL] [Abstract][Full Text] [Related]  

  • 95. CD4+ CD45RA+ and CD4+ CD45RO+ T cells differ in their TCR-associated signaling responses.
    Hall SR; Heffernan BM; Thompson NT; Rowan WC
    Eur J Immunol; 1999 Jul; 29(7):2098-106. PubMed ID: 10427972
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Constitutively oxidized CXXC motifs within the CD3 heterodimeric ectodomains of the T cell receptor complex enforce the conformation of juxtaposed segments.
    Brazin KN; Mallis RJ; Li C; Keskin DB; Arthanari H; Gao Y; Wu SL; Karger BL; Wagner G; Reinherz EL
    J Biol Chem; 2014 Jul; 289(27):18880-92. PubMed ID: 24849600
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Inhibition of antigen-receptor signaling by Platelet Endothelial Cell Adhesion Molecule-1 (CD31) requires functional ITIMs, SHP-2, and p56(lck).
    Newman DK; Hamilton C; Newman PJ
    Blood; 2001 Apr; 97(8):2351-7. PubMed ID: 11290597
    [TBL] [Abstract][Full Text] [Related]  

  • 98. THEMIS-SHP1 Recruitment by 4-1BB Tunes LCK-Mediated Priming of Chimeric Antigen Receptor-Redirected T Cells.
    Sun C; Shou P; Du H; Hirabayashi K; Chen Y; Herring LE; Ahn S; Xu Y; Suzuki K; Li G; Tsahouridis O; Su L; Savoldo B; Dotti G
    Cancer Cell; 2020 Feb; 37(2):216-225.e6. PubMed ID: 32004441
    [TBL] [Abstract][Full Text] [Related]  

  • 99. T cell engineered with a novel nanobody-based chimeric antigen receptor against VEGFR2 as a candidate for tumor immunotherapy.
    Hajari Taheri F; Hassani M; Sharifzadeh Z; Behdani M; Arashkia A; Abolhassani M
    IUBMB Life; 2019 Sep; 71(9):1259-1267. PubMed ID: 30724452
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2
    Priceman SJ; Tilakawardane D; Jeang B; Aguilar B; Murad JP; Park AK; Chang WC; Ostberg JR; Neman J; Jandial R; Portnow J; Forman SJ; Brown CE
    Clin Cancer Res; 2018 Jan; 24(1):95-105. PubMed ID: 29061641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.